Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines.

× No keyword cloud information.

11 in total

1. HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-κB pathway.

Authors: Ankit Shah; Dhirendra P Singh; Shilpa Buch; Anil Kumar
Journal: Biochem Biophys Res Commun Date: 2011-09-14 Impact factor: 3.575

2. Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells.

Authors: Susan B Glantz; Carol D Cianci; Rathna Iyer; Deepti Pradhan; Kevin K W Wang; Jon S Morrow
Journal: Biochemistry Date: 2007-01-16 Impact factor: 3.162

3. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.

Authors: V C Asensio; J Maier; R Milner; K Boztug; C Kincaid; M Moulard; C Phillipson; K Lindsley; T Krucker; H S Fox; I L Campbell
Journal: J Virol Date: 2001-08 Impact factor: 5.103

4. Platelet-derived growth factor protects neurons against gp120-mediated toxicity.

Authors: Fuwang Peng; Navneet Dhillon; Shannon Callen; Honghong Yao; Sirosh Bokhari; Xuhui Zhu; Hicham H Baydoun; Shilpa Buch
Journal: J Neurovirol Date: 2008-01 Impact factor: 2.643

5. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain.

Authors: C J Heyser; E Masliah; A Samimi; I L Campbell; L H Gold
Journal: Proc Natl Acad Sci U S A Date: 1997-02-18 Impact factor: 11.205

10. Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies.

Authors: Andrew O Koob; Kiren Ubhi; Johan F Paulsson; Jeffery Kelly; Edward Rockenstein; Michael Mante; Anthony Adame; Eliezer Masliah
Journal: Exp Neurol Date: 2009-11-26 Impact factor: 5.330

Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines.

1. HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-κB pathway.

2. Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells.

3. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.

4. Platelet-derived growth factor protects neurons against gp120-mediated toxicity.

5. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain.

Review 6. In vivo modeling of HIV-1 mediated neurodegeneration.

Review 7. HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Review 8. Physiological and pathological roles of interleukin-6 in the central nervous system.

9. Neuronal toxicity in HIV CNS disease.

10. Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies.